Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Luke, Jason J."" wg kryterium: Autor

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 105
Tytuł:
Perspectives in Melanoma: meeting report from the Melanoma Bridge (December 3rd-5th, 2020, Italy).
Autorzy:
Ascierto PA; Department of Melanoma, Cancer Immunotherapy and Innovative Therapy, Instituto Nazionale Tumori IRCCS 'Fondazione G. Pascale', Naples, Italy. .
Blank C; Netherlands Cancer Institute, Amsterdam, The Netherlands.
Dummer R; Department of Dermatology, University of Zurich Hospital, Zurich, Switzerland.
Ernstoff MS; Developmental Therapeutics Program, Division of Cancer Therapy & Diagnosis, NCI, NIH, Bethesda, MD, USA.
Ferrone S; Department of Surgery Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Fox BA; Earle A. Chiles Research Institute, Robert W. Franz Cancer Center, Providence Cancer Institute, Portland, OR, USA.
Gajewski TF; Department of Pathology and Department of Medicine (Section of Hematology/Oncology), University of Chicago, Chicago, IL, USA.
Garbe C; Center for Dermato-Oncology, University-Department of Dermatology, Tuebingen, Germany.
Hwu P; Moffitt Cancer Center, Tampa, FL, USA.
Kalinski P; Cancer Vaccine and Dendritic Cell Therapies, Center for Immunotherapy, Roswell Park Comprehensive Cancer Center, Developmental Therapeutics, Buffalo, NY, USA.
Krogsgaard M; Medical School, New York University Langone, New York, NY, USA.
Lo RS; Jonsson Comprehensive Cancer Center David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
Luke JJ; Cancer Immunotherapeutic Center of UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.
Neyns B; Medical Oncology, Universitair Ziekenhuis Brussel, Brussels, Belgium.
Postow MA; Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Weill Cornell Medical College, New York, NY, USA.
Quezada SA; Cancer Immunology Unit, Research Department of Hematology, University College London Cancer Institute, London, UK.
Teng MWL; QIMR Berghofer Medical Research Institute, Herston, QLD, Australia.
Trinchieri G; Laboratory of Integrative Cancer Immunology (LICI), Center for Cancer Research, NCI, NIH, Bethesda, MD, USA.
Testori A; Image Rigenerative Clinic-Skin Oncology Division, Milan, Italy.; Chairman Surgical Subgroup EORTC Melanoma Group Brussels, Brussels, Belgium.
Caracò C; Division of Surgery of Melanoma and Skin Cancer, Istituto Nazionale Tumori 'Fondazione Pascale' IRCCS, Naples, Italy.
Osman I; New York University Langone Medical Center, New York, NY, USA.
Puzanov I; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Thurin M; Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, NCI, NIH, Rockville, MD, USA.
Pokaż więcej
Źródło:
Journal of translational medicine [J Transl Med] 2021 Jun 30; Vol. 19 (1), pp. 278. Date of Electronic Publication: 2021 Jun 30.
Typ publikacji:
Congress
MeSH Terms:
Immunotherapy*
Melanoma*/drug therapy
Humans ; Italy ; Molecular Targeted Therapy ; Tumor Microenvironment
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Perspectives in melanoma: meeting report from the "Melanoma Bridge" (December 5th-7th, 2019, Naples, Italy).
Autorzy:
Ascierto PA; Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori IRCCS 'Fondazione G. Pascale', Via Mariano Semmola, 80131, Naples, Italy. .
Puzanov I; Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Agarwala SS; Temple University School of Medicine, Philadelphia, PA, USA.
Blank C; Netherlands Cancer Institute, Amsterdam, The Netherlands.
Carvajal RD; Columbia University Irving Medical Center, Herbert Irving Comprehensive Cancer Center, New York, NY, USA.
Demaria S; Department of Radiation Oncology, Weill Cornell Medicine, New York, NY, USA.; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.
Dummer R; Department of Dermatology, University of Zurich Hospital, Zurich, Switzerland.
Ernstoff M; Roswell Park Comprehensive Cancer Center, Jacobs School of Medicine and Biomedical Sciences, State University, Buffalo, NY, USA.
Ferrone S; Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Fox BA; Earle A. Chiles Research Institute, Robert W. Franz Cancer Research Center, Providence Cancer Institute, Portland, OR, USA.
Gajewski TF; Department of Pathology, University of Chicago, Chicago, IL, USA.; Department of Medicine (Section of Haematology/Oncology), University of Chicago, Chicago, IL, USA.
Garbe C; Center for Dermatooncology, Department of Dermatology, Eberhard Karls University, Tübingen, Germany.
Hwu P; Department of Melanoma Medical Oncology, Division of Cancer Medicine, Anderson Cancer Center, Houston, TX, USA.
Lo RS; Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
Long GV; Melanoma Institute Australia, The University of Sydney and Royal North Shore and Mater Hospitals, Sydney, Australia.
Luke JJ; Medicine University of Chicago, Chicago, IL, USA.
Osman I; The Interdisciplinary Melanoma Program, New York University Langone Medical Center, NYU Grossman Medical School, New York, NY, USA.
Postow MA; Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA.
Sullivan RJ; Melanoma Program, Mass General Cancer Center, Boston, MA, USA.
Taube JM; Division of Dermatopathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Trinchieri G; Laboratory of Integrative Cancer Immunology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Zarour HM; Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.
Caracò C; Department Melanoma, Soft Tissue, Muscle-Skeletal and Head-Neck, Istituto Nazionale Tumori IRCCS 'Fondazione G. Pascale', Naples, Italy.
Thurin M; Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, NCI, Bethesda, MD, USA.
Pokaż więcej
Źródło:
Journal of translational medicine [J Transl Med] 2020 Sep 07; Vol. 18 (1), pp. 346. Date of Electronic Publication: 2020 Sep 07.
Typ publikacji:
Journal Article
MeSH Terms:
Immunotherapy*
Melanoma*/therapy
CTLA-4 Antigen ; Combined Modality Therapy ; Humans ; Italy ; Tumor Microenvironment
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
BMI, irAE, and gene expression signatures associate with resistance to immune-checkpoint inhibition and outcomes in renal cell carcinoma.
Autorzy:
Labadie BW; Department of Internal Medicine, University of Chicago, Chicago, IL, USA.
Liu P; Department of Public Health Sciences, University of Chicago, Chicago, IL, USA.
Bao R; Hillman Cancer Center, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.; Division of Hematology/Oncology, University of Pittsburgh, Pittsburgh, PA, USA.
Crist M; Division of Hematology/Oncology, New York University School of Medicine and Langone Medical Center, New York, NY, USA.
Fernandes R; Division of Medical Oncology, Schulich School of Medicine & Dentistry, Western University and London Health Sciences Centre, London, ON, Canada.
Ferreira L; Division of Medical Oncology, University Hospital Marques de Valdecilla, Cantabria, Spain.
Graupner S; Division of Hematology/Oncology, Virginia Commonwealth University, Richmond, VA, USA.
Poklepovic AS; Division of Hematology/Oncology, Virginia Commonwealth University, Richmond, VA, USA.
Duran I; Division of Medical Oncology, University Hospital Marques de Valdecilla, Cantabria, Spain.
Maleki Vareki S; Division of Medical Oncology, Schulich School of Medicine & Dentistry, Western University and London Health Sciences Centre, London, ON, Canada.
Balar AV; Division of Hematology/Oncology, New York University School of Medicine and Langone Medical Center, New York, NY, USA.
Luke JJ; Hillman Cancer Center, University of Pittsburgh Medical Center, Pittsburgh, PA, USA. .; Division of Hematology/Oncology, University of Pittsburgh, Pittsburgh, PA, USA. .
Pokaż więcej
Źródło:
Journal of translational medicine [J Transl Med] 2019 Nov 25; Vol. 17 (1), pp. 386. Date of Electronic Publication: 2019 Nov 25.
Typ publikacji:
Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:
Body Mass Index*
Gene Expression Profiling*
Gene Expression Regulation, Neoplastic*
Carcinoma, Renal Cell/*genetics
Carcinoma, Renal Cell/*therapy
Immunotherapy/*adverse effects
Kidney Neoplasms/*genetics
Kidney Neoplasms/*therapy
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Carcinoma, Renal Cell/immunology ; Databases, Genetic ; Disease Progression ; Female ; Humans ; Kaplan-Meier Estimate ; Kidney Neoplasms/immunology ; Male ; Middle Aged ; Neovascularization, Pathologic/genetics ; T-Lymphocytes/immunology ; Treatment Outcome ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients.
Autorzy:
Matson V; Department of Pathology, University of Chicago, Chicago, IL 60637, USA.
Fessler J; Department of Pathology, University of Chicago, Chicago, IL 60637, USA.
Bao R; Center for Research Informatics, University of Chicago, IL 60637, USA.; Department of Pediatrics, University of Chicago, IL 60637, USA.
Chongsuwat T; Department of Medicine, University of Chicago, Chicago, IL 60637, USA.
Zha Y; Department of Medicine, University of Chicago, Chicago, IL 60637, USA.
Alegre ML; Department of Medicine, University of Chicago, Chicago, IL 60637, USA.
Luke JJ; Department of Medicine, University of Chicago, Chicago, IL 60637, USA.
Gajewski TF; Department of Pathology, University of Chicago, Chicago, IL 60637, USA.; Department of Medicine, University of Chicago, Chicago, IL 60637, USA.
Pokaż więcej
Źródło:
Science (New York, N.Y.) [Science] 2018 Jan 05; Vol. 359 (6371), pp. 104-108.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:
Gastrointestinal Microbiome/*immunology
Immunotherapy/*methods
Melanoma/*therapy
Programmed Cell Death 1 Receptor/*antagonists & inhibitors
Skin Neoplasms/*therapy
Animals ; Antibodies, Monoclonal/therapeutic use ; Bifidobacterium longum/classification ; Bifidobacterium longum/genetics ; Bifidobacterium longum/immunology ; Bifidobacterium longum/isolation & purification ; Enterococcus faecium/classification ; Enterococcus faecium/genetics ; Enterococcus faecium/immunology ; Enterococcus faecium/isolation & purification ; Feces/microbiology ; Gastrointestinal Microbiome/genetics ; Humans ; Melanoma/immunology ; Mice ; RNA, Ribosomal, 16S/genetics ; Skin Neoplasms/immunology ; T-Lymphocytes/immunology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The “Great Debate” at Melanoma Bridge 2022, Naples, December 1st–3rd, 2022
Autorzy:
Ascierto, Paolo A.Aff1, IDs1296702304100y_cor1
Blank, Christian
Eggermont, Alexander M.Aff3, Aff4
Garbe, Claus
Gershenwald, Jeffrey E.
Hamid, Omid
Hauschild, Axel
Luke, Jason J.
Mehnert, Janice M.
Sosman, Jeffrey A.
Tawbi, Hussein A.
Mandalà, Mario
Testori, Alessandro
Caracò, Corrado
Osman, Iman
Puzanov, Igor
Pokaż więcej
Źródło:
Journal of Translational Medicine. 21(1)
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The “Great Debate” at Melanoma Bridge 2021, December 2nd–4th, 2021
Autorzy:
Ascierto, Paolo A.Aff1, IDs12967022034067_cor1
Warner, Allison Betof
Blank, Christian
Caracò, Corrado
Demaria, Sandra
Gershenwald, Jeffrey E.
Khushalani, Nikhil I.
Long, Georgina V.Aff8, Aff9, Aff10, Aff11
Luke, Jason J.
Mehnert, Janice M.
Robert, Caroline
Rutkowski, Piotr
Tawbi, Hussein A.
Osman, Iman
Puzanov, Igor
Pokaż więcej
Źródło:
Journal of Translational Medicine. 20(1)
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 105

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies